May 2010 Issue of MMM
Even though it's now been 13 years since the first ever TV commercial for a prescription drug brand debuted on our TV screens--Claritin's "Blue Skies"--the ...
US branded drug sales saw a modest bump in 2009, but maybe hold off on the champagne, because generics are still surging and another wave ...
All too often in pharmaceutical advertising, somewhere between the initial idea and the finished product, the communication—and the originality—disappears. Ross Thomson and Craig Sponseller, MD, ...
Asking physicians what they want can be a fruitless task. Meaghan Onofrey believes the solution lies in ethnographic research
On March 1, six months after Publicis acquired digital powerhouse Razorfish from Microsoft, Razorfish Health launched as a standalone shop.
The deadline to enter the MM&M Awards is less than a month away but rest assured that once again your entries will be in the ...
The more things change, the more they stay the same. Will this adage hold true for healthcare?
The problem with media headlines on pharma is that they are rarely subtle or nuanced, instead they smear and cripple some of our best medications.
When patents expire on brands like Merck's cholesterol pill Zocor, million-dollar ad budgets usually fizzle as cheap generic competition takes over the market.
A "sell sheet" used to promote Rozerem to doctors contained unsubstantiated superiority claims and omitted risks associated with the drug, according to an untitled DDMAC ...
Sanofi-Aventis laid off 400 reps in April as part of a strategy to focus on key therapeutic areas.
Featuring news about Sanofi-Aventis, Warner Chilcott, Novartis and PharmaShine
Med Ed Report
The Apple iPad gives physicians a new way to connect to courses, news and other educational content. But surveys disagree on whether medicine will adapt ...
Pfizer paid out $35 million to 4,500 healthcare professionals in the second half of 2009, the company reported.
Stanford adjunct clinical faculty must follow the same policies as full-time faculty and thus are prohibited from accepting industry gifts of any size, including drug ...
Featuring news about Cordis Corporation, American College of Physicians, National Institute of Mental Health and Georgetown University Medical Center
First Lady Michelle Obama's recent announcement of a campaign to end childhood obesity was not lost on medical publisher Mary Ann Liebert, Inc., which will ...
The Association of Medical Media named Joe Dennehy of the Cleveland Clinic and Megan Boorjian of Quadrant as its 18th annual Nexus Representatives of the ...
Featuring news about GlaxoSmithKline, International Committee of Medical Journal Editors, Monthly Prescribing Reference and the American Medical Association
Spanish-language network TV ad spend nearly tripled in 2009, while its cable spend quadrupled. What happened? Did pharmas just discover these demographics, and will we ...
Pfizer is experimenting with electronic medical records and mobile technology to detect safety issues sooner.
Even when factors like education level, income and age are accounted for, adults with chronic diseases are still less likely to go online or have ...
Featuring news about Healthline Networks, iVillage and the Internet Advertising Bureau
Some DTC ads develop from a key consumer insight that points to brand essence and leads to a great creative idea.
GlaxoSmithKline launched new TV spots last month for Lovaza, a prescription omega-3 fish oil capsule indicated for the lowering of very high triglyceride levels.
Consumers are skeptical of pharma participation in social media, but endorsements by government and nonprofit organizations add credibility, according to an Epsilon survey.
Takeda is observing Irritable Bowel Syndrome (IBS) Awareness Month with the launch of an unbranded website for patients called Let's Talk IBS.
Spring is in the air, and that means, well, sure, robins, daffodils, love and all that, but more importantly, campaigns for allergy drugs featuring endorsements ...
Featuring news about Merck, Schering-Plough HealthCare Products, Resolute Communications and Shire
Four marketing research company CEOs reflected on the future of their industry, that of pharmas and on their firms' relationships with pharmas at the Pharmaceutical ...
New York-based LyonHeart hired Steven Hébert to lead its creative department, the agency said.
Cline, Davis & Mann acquired agencies in Paris, Milan and Montreal, fleshing out a planned global expansion that has placed CDM World Agency shops in ...
Featuring news about MS&L Group, Publicis Healthcare Communications Group, In-Sync Customer Insights, Hacker Group, HealthHG and MicroMass Communications
So how's it workin' out for ya--all this new Obama transparency stuff?
Based in part on testimony from former FDA commissioner David Kessler, a Massachusetts federal jury has found Pfizer guilty of violating racketeering laws in marketing ...
Washington attorneys Thomas Barker and Barrett Thornhill (Foley Hoag) say in an on-line report that the new healthcare reform law imposes an annual fee on ...
I have a friend at a big digital agency. And the talk in his firm is about becoming the agency of the future, and "obsoleting" ...
Now that the fight over the healthcare bill is over and the election-cycle fight over its repeal is just beginning, I decided to step away ...
Many people regard pharmaceutical firms as a necessary evil—they deliver life-saving products but are also to blame for rising healthcare costs. With the industry facing ...
- Biogen ends Tecfidera DTC campaign, citing prescriptions
- Five things for pharma marketers to know: Tuesday, July 19, 2016
- Five things for pharma marketers to know: Thursday, July 21, 2016
- As immuno-oncology therapies evolve, so will the marketing
- Five things for pharma marketers to know: Wednesday, July 20, 2016
- Merck educates doctors about biosimilars, long before it will sell one in the U.S.
- 4 trends with the potential to change behavior in the patient journey
- 2016 Pharma Report: All the data in one place
- What do physicians think about biosimilars?
- Novartis considers new sales model for experimental cancer therapy